Alanna Church, MD Nature Medicine Alyaa Al-Ibraheemi Seth Pinches Brian Crompton Laura Macconaill Dana-Farber/Boston Children's Dana-Farber Boston Children's @SamVolchenboum The Janeway Lab It has been great working with Alanna Church, MD , colleagues from 16 institutions, and patients and families on this report from the GAIN consortium/iCat2 study addressing the clinical impact of targeted NGS in pediatric solid tumors. Collaboration is key for rare cancers!

An interim report from the GAIN/iCat2 study shows that molecular profiling of pediatric solid malignancies clarifies diagnostic classifications and provides opportunities for matched targeted therapy Katie Janeway The Janeway Lab, Alanna Church, MD nature.com/articles/s4159…

Nature Medicine Alanna Church, MD Katie Janeway The Janeway Lab Congratulations Alanna Church, MD, Katie Janeway, and all!

Nicolas Robine Nature Medicine Katie Janeway Alyaa Al-Ibraheemi Seth Pinches Brian Crompton Laura Macconaill Dana-Farber/Boston Children's Dana-Farber Boston Children's @SamVolchenboum The Janeway Lab All of the data is available in the supplement for the manuscript. The fusions in this cohort are DNAJB1::PRKACA in fibrolamellar carcinoma, an entity beautifully described by Alli O'Neill, MD here: sciencedirect.com/science/articl…

Excited #CCDI Molecular characterization initiative of Children’s Oncology Group now enrolling #sarcoma! Molecular tumor profiling of enrolled patients Nationwide Children's Hospital is similar DNA and RNA sequencing as our study just published in Nature Medicine showing clinical benefit: nature.com/articles/s4159…

This team <3 The Janeway Lab Katie Janeway Hannah Comeau

An incredibly gifted writer, a bright soul, and an ARMS warrior, Kasey Altman. Rest in the sweetest peace.

Getting ready for my presentation 👩‍💼this afternoon at 3p ET. Please join us for this free webinar to get to know MIB Agents Osteosarcoma Alliance and to hear about how molecular profiling is helping #ChildhoodCancer The Nature Medicine paper is available here: rdcu.be/cQgmj

An interim report from the GAIN/iCat2 study shows that molecular profiling of pediatric solid malignancies clarifies diagnostic classifications and provides opportunities for matched targeted therapy Katie Janeway The Janeway Lab Alanna Church, MD nature.com/articles/s4159…

A new study published in Nature Medicine found that 86 percent of extracranial solid tumors in pediatric patients had genomic alterations. Learn more about the findings from lead author Dr. Alanna Church Alanna Church, MD in HealthDay News. bit.ly/3PSbW4y.

86% of pediatric cancer patients w extracranial solid tumors have genomic alterations that potentially impact clinical care. Important somatic sequencing results from the GAIN/iCAT2 study.Beautiful work Alanna Church, MD Katie Janeway The Janeway Lab et al. go.nature.com/3BP9c40

“All authors have contributed equally to this manuscript”

We are excited to share our recent publication in JCO Precision Oncology, "FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer.” Thank you to all our collaborators and co-authors! ascopubs.org/doi/abs/10.120…

Pediatric Cancer Working Group session #AACR2023 #osteosarcoma The Osteosarcoma Institute Katie Janeway Huntsman Cancer Institute Dana-Farber #MIBagents #MakeItBetter

Join us, Dana-Farber, and National Cancer Institute on May 25 for an informational webinar to hear more about our work in #osteosarcoma (OS) and #leiomyosarcoma (LMS) research. Register at: bit.ly/OSLMSNCI. PE-CGS #CancerMoonshot #HealthEquity #Oncology #PatientResearch #PECGS

Excited to present on our patient partnered research on osteosarcoma and leiomyosarcoma next month!!

⁦So happy to see work done by Maeve Smart ⁦The Janeway Lab⁩ about Covid-19 infection in pediatric cancer patients at #ASCO2023

Awesome getting to see Maeve from The Janeway Lab and MIB Agents Osteosarcoma Alliance present a poster at #ASCO23!

It is the anniversary of our patient partnered osteosarcoma project — osproject.org — creating a clinico-genomic database for the research community to drive discovery. Patients enroll online. Consider referring your patients during #childhoodcancerawareness month

New work from the The Janeway Lab reporting on a pediatric cancer patient cohort sequenced Dana-Farber with 95! different cancer diagnoses. So important to share data to learn about Rare Cancer rdcu.be/dNt1d